BIOSECURE Act of 2025

S 3469, the BIOSECURE Act of 2025, prohibits U.S. federal agencies from contracting with or using biotechnology equipment/services from companies identified as "biotechnology companies of concern" (primarily those linked to foreign adversaries like China that pose national security risks, such as through unauthorized collection of genetic data). It directly affects federal agencies, contractors, and grant recipients by banning purchases or contracts involving such companies' products, with exceptions for intelligence activities, overseas health care for military personnel, and public health emergencies. Key mechanisms include a defined list of prohibited companies (updated annually), waiver options for national security needs (requiring congressional notice), and strict rules for identifying risks related to multiomic data (genomic, proteomic, etc.). The law aims to prevent U.S. citizens' biological data from being exploited by foreign adversaries through federal contracts.